Table 3.
A comparison between EORTC QLQ-C30 mean values (SD) in the cohort in the present study vs those published by Bjordal et al. and that were used as a control group [15]. *Significant difference with a p-value < 0.05
| EORTC QLQ-C30 Scales | Overall population (121) | Control group (360) | p-value |
|---|---|---|---|
| Physical functioning | 80.5 (21.1) | 85 (18.8) | 0.028* |
| Role functioning | 78 (28.5) | 84 (25.4) | 0.030* |
| Emotional functioning | 76 (24.4) | 81 (22.8) | 0.041* |
| Cognitive functioning | 89 (17.3) | 86 (19.8) | 0.138 |
| Social functioning | 82.4 (26) | 86 (22.8) | 0.148 |
| Fatigue | 22.8 (26.3) | 21 (23.6) | 0.481 |
| Nausea/vomiting | 2.9 (10.7) | 5 (13.3) | 0.116 |
| Pain | 11.2 (22.3) | 15 (23) | 0.114 |
| Dyspnea | 16 (26.2) | 20 (29.5) | 0.185 |
| Insomnia | 22 (33.2) | 22 (30.5) | 1 |
| Appetite loss | 12.1 (24.7) | 13 (25.8) | 0.737 |
| Constipation | 11.4 (30.5) | 11 (23.6) | 0.881 |
| Diarrhea | 6.1 (17.7) | 5 (16) | 0.525 |
| Financial difficulties | 14.6 (29.5) | 14 (27.6) | 0.839 |
| Global health status | 71 (20.5) | 73 (21.7) | 0.374 |